medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2013, Number 2

<< Back Next >>

Rev Esp Med Quir 2013; 18 (2)

Medical Treatment Guides of Non-Small Cell Lung Cancer at ISSSTE

Erazo VSAA, Hernández HCA, Aldaco SF, Franco GE

Language: Spanish
References: 7
Page: 138-141
PDF size: 352.57 Kb.


Text Extraction

No abstract


REFERENCES

  1. Solomon SB, Zakowski MF, Pao W, Thornton RH, et al. Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis. AJR Am J Roentgenol 2010;194:266-269.

  2. Pirker R, Herth F, Kerr KM, Filipits M, et al. Consensus for EGFR mutation testing in non-small cell lung cancer. J Thorac Oncol 2010;5:1706-1713.

  3. Shaw A, Hayes N, Martins R. The importance of histology and molecular testing (EGFR and EML4-ALK) in the initial evaluation of advanced non-small cell lung cancer. Educational Book ASCO 2011.

  4. Aisner DL, Marshall CB. Molecular pathology of nonsmall cell lung cancer. A practical guide. Am J Clin Pathol 2012;138:332-346.

  5. Herbst RS, Heymach JV, Lippman SM. Molecular origins of lung cancer. N Engl J Med 2008;359:1367-1380.

  6. Angulo B, Conde E, Suárez-Gauthier A, Plaza C, et al. Comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry. PLoS One 2012;7(8):e43842. doi: 10.1371/journal.pone.0043842. Epub 2012 Aug 27.

  7. Pirker R, Herth F, Kerr KM, Filipits M, et al. Consensus for EGFR mutation testing in non-small cell lung cancer. J Thorac Oncol 2010;5:1706-1713.




2020     |     www.medigraphic.com